Adequacy of Using Consensus Guidelines for Diagnosis of Dementia with Lewy Bodies in Clinical Trials for Drug Development | Zendy

Manabu Ikeda | Zendy; Etsuro Mori | Zendy; Eizo Iseki | Zendy; Sadao Katayama | Zendy; Yasuto Higashi | Zendy; Mamoru Hashimoto | Zendy; Hideaki Miyagishi | Zendy; Masaki Nakagawa | Zendy; Kenji Kosaka | Zendy

Open Access

Adequacy of Using Consensus Guidelines for Diagnosis of Dementia with Lewy Bodies in Clinical Trials for Drug Development

Author(s) -

Manabu Ikeda,

Etsuro Mori,

Eizo Iseki,

Sadao Katayama,

Yasuto Higashi,

Mamoru Hashimoto,

Hideaki Miyagishi,

Masaki Nakagawa,

Kenji Kosaka

Publication year - 2015

Publication title -

dementia and geriatric cognitive disorders

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.026

H-Index - 110

eISSN - 1421-9824

pISSN - 1420-8008

DOI - 10.1159/000441443

Subject(s) - dementia with lewy bodies , dementia , drug trial , drug development , clinical trial , psychology , medicine , degenerative disease , drug , psychiatry , central nervous system disease , disease , neuroscience , pathology

To evaluate the adequacy of using the consensus diagnostic criteria for dementia with Lewy bodies (DLB) to recruit patients with homogeneous characteristics in future clinical trials, where multiple departments of multinational centres are expected to participate with a long enrolment period, and additionally, to contribute to the possible future criteria revision.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research